$ONCO #Oncopeptides AB Oncopeptides - FDA filing coming up: We expect FDA filing during Q2’20 We compare timelines with XPOVIO (selinexor) Reiterate BUY for our top pick in the sector https://t.co/4ww3FkQ7lU #equity #stocks https://t.co/jDTv3ZsN44